These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6252166)

  • 1. Antibacterial activity of cefotaxime and other newer cephalosporins (in vitro and in vivo).
    Schrinner E; Limbert M; Penasse L; Lutz A
    J Antimicrob Chemother; 1980 Sep; 6 Suppl A():25-30. PubMed ID: 6252166
    [No Abstract]   [Full Text] [Related]  

  • 2. Emerging bacterial resistance to the newer cephalosporins.
    Towner KJ
    J Antimicrob Chemother; 1984 May; 13(5):526-7. PubMed ID: 6610675
    [No Abstract]   [Full Text] [Related]  

  • 3. Diastereomeric 7-alpha-ureidoacetyl cephalosporins. V. Antimicrobial activity, beta-lactamase stability and pharmacokinetics of 7-(alpha-ureido-2-amino-4-thiazolylacetyl)-cephalosporins.
    Polacek I; Starke B
    J Antibiot (Tokyo); 1980 Sep; 33(9):1031-6. PubMed ID: 6969250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime.
    Masuyoshi S; Hiraoka M; Inoue M; Tomatsu K; Hirano M; Mitsuhashi S
    Drugs Exp Clin Res; 1989; 15(1):1-10. PubMed ID: 2663406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial activity of cefotaxime.
    Mitsuhashi S; Inoue M; Masuyoshi S
    J Antimicrob Chemother; 1980 Sep; 6 Suppl A():37-46. PubMed ID: 6252177
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative in vitro activity of 5 cephalosporins with other antibiotics tested against 887 recent clinical isolates.
    Wasilauskas BL
    Chemotherapy; 1981; 27(6):416-22. PubMed ID: 7297171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefotaxime and amikacin: results of in vitro and in vivo studies against Gram-negative bacteria and Staphylococcus aureus. EORTC International Antimicrobial Therapy Project Group.
    Klastersky J; Gaya H; Zinner SH; Bernard C; Ryff JC
    J Antimicrob Chemother; 1980 Sep; 6 Suppl A():55-61. PubMed ID: 6252180
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro and in vivo microbiological evaluations of cefoperazone.
    Renzini G; Ravagnan G; Piccolomini R; Dainelli B; Comanducci A
    Clin Ther; 1980; 3(Spec Issue):139-44. PubMed ID: 6446388
    [No Abstract]   [Full Text] [Related]  

  • 9. [In vitro bacteriostatic activity of cefmenoxime (SCE 1365), cefotaxime and moxalactam].
    Husson MO; Bryskier A; Izard D; Leclerc H
    Pathol Biol (Paris); 1983 May; 31(5):347-50. PubMed ID: 6312395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory evaluation of ceftizoxime, a new parenteral cephalosporin.
    Kamimura T; Matsumoto Y; Shigi Y; Nishida M
    Arzneimittelforschung; 1980; 30(10):1662-4. PubMed ID: 6969078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The in vitro antibacterial activity of cefotaxime compared with that of cefuroxime and cefoxitin.
    King A; Warren C; Shannon K; Phillips I
    J Antimicrob Chemother; 1980 Jul; 6(4):479-94. PubMed ID: 6253433
    [No Abstract]   [Full Text] [Related]  

  • 12. [Possibilities for the use of basic cephalosporins].
    Rodloff AC; Knothe H
    Infection; 1993; 21 Suppl 1():S10-3. PubMed ID: 8314286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diastereomeric 7-ureidoacetyl cephalosporins. III. Contribution of D- and L-isomers to the growth inhibiting activities of 7alpha-H and 7alpha-OCH3 derivatives for gram-positive and gram-negative bacteria.
    Gadebusch HH; Basch HI; Lukaszow P; Remsburg B; Schwind R
    J Antibiot (Tokyo); 1978 Jun; 31(6):570-9. PubMed ID: 681238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro antibacterial activity of eight third generation cephalosporins (author's transl)].
    Deforges L; Le Van Thoi J; Soussy CJ; Duval J
    Pathol Biol (Paris); 1982 Jun; 30(6):363-9. PubMed ID: 6810282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo activity of DQ-2556, a new cephalosporin.
    Ishida Y; Miyazaki S; Yamaguchi K; Goto S
    Chemotherapy; 1995; 41(1):5-13. PubMed ID: 7875022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Third generation cephalosporins, monobactams and carbapenems].
    Perronne C; Vildé JL
    Rev Prat; 1988 Mar; 38(8):469-76. PubMed ID: 3163818
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro activity of cefotaxime and other cephalosporins against Neisseria gonorrhoeae.
    Piot P; Van Dyck E; Colaert J; Ursi JP
    J Antimicrob Chemother; 1980 Sep; 6 Suppl A():47-50. PubMed ID: 6252178
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative activity of cefoperazone against selected cephalosporinase-producing enteric bacteria.
    Chabbert YA; Collatz E
    Clin Ther; 1980; 3(Spec Issue):98-102. PubMed ID: 6446402
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro and in vivo antibacterial activity of cefoperazone.
    Mitsuhashi S; Minami S; Matsubara N; Yotsuji A; Kurashige S; Saikawa I
    Clin Ther; 1980; 3(Spec Issue):1-13. PubMed ID: 6446381
    [No Abstract]   [Full Text] [Related]  

  • 20. Delineation of the relative antibacterial activity of cefamandole and cefamandole nafate.
    Turner JR; Preston DA; Wold JS
    Antimicrob Agents Chemother; 1977 Jul; 12(1):67-72. PubMed ID: 18988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.